NEUROSENSE THERAPEUTICS LTD's ticker is and the CUSIP is M74240116. A total of 5 filers reported holding NEUROSENSE THERAPEUTICS LTD in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $27,760 | +33.9% | 173,506 | +97.8% | 0.00% | – |
| Q2 2023 | $20,732 | -77.0% | 87,734 | -70.8% | 0.00% | – |
| Q1 2023 | $90,000 | +200.0% | 300,000 | +100.0% | 0.00% | – |
| Q4 2022 | $30,000 | -6.2% | 150,000 | 0.0% | 0.00% | – |
| Q3 2022 | $32,000 | -60.5% | 150,000 | 0.0% | 0.00% | -100.0% |
| Q2 2022 | $81,000 | -10.0% | 150,000 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $90,000 | -34.3% | 150,000 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $137,000 | – | 150,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Empery Asset Management, LP | 160,000 | $82,000 | 0.44% |
| Warberg Asset Management LLC | 77,100 | $39,000 | 0.01% |
| CLEAR STREET LLC | 52,458 | $27,000 | 0.00% |
| Hudson Bay Capital Management LP | 150,000 | $81,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |